Ethanol is an important risk factor for the occurrence of cerebral ischemia contributing to poor prognosis and inefficacy of drug treatments for stroke-related symptoms. Females have a higher lifetime risk for stroke than males. Moreover, female gender has been associated with increased ethanol consumption during adolescence. In the present study, we investigated whether chronic ethanol exposure during adolescence may potentiate the motor impairments and cortical damage induced by focal ischemia in female rats. We also addressed whether these effects can be mitigated by minocycline, which has been shown to be neuroprotective against different insults in the CNS. Female rats were treated with distilled water or ethanol (6.5 g/kg/day, 22.5% w/v) for 55 days by gavage. Focal ischemia was induced by microinjections of endothelin-1 (ET-1) into the motor cortex. Animals of both groups were treated daily with minocycline (25-50 mg/kg, i.p.) or sterile saline (i.p.) for 5 days, and motor function was assessed using open field, inclined plane and rotarod tests. Chronic ethanol exposure http://dx
Introduction
Ethanol is the most widely used drug of abuse among adolescents due to its easy acquisition and wide acceptance by the majority of organized societies (Sanchis and Aragón, 2007; Schuckit, 2009) . Early use of this substance has been linked to higher incidence of alcoholism in adulthood, given that over 80% of regular drinkers reported problems related to alcohol before the age of 30 and 40% between 15 and 19 years of age (Chambers et al., 2003) . The high consumption of ethanol during adolescence negatively impacts individuals, such as increased susceptibility to brain damage and cognitive and behavioral disabilities for both rodents and humans (Alfonso-Loeches and Guerri, 2011) . This is a critical period of central nervous system (CNS) maturation, in which establishment of neurotransmission pathways and synaptic connections occur, resulting in long-term deleterious effects of ethanol on behavior (Crews et al., 2006; Slawecki et al., 2004; White and Swartzwelder, 2004) .
Otero Palleiro and Barbagelata López (2007) showed that prolonged exposure to ethanol was responsible for 16% of cases of cerebral ischemia in patients between 18 and 45 years of age. Other studies have described that consumption of ethanol exacerbates the occurrence of cerebral ischemia in a dose-dependent manner, contributing to poor prognosis and failure of treatment for stroke-related symptoms (Iso et al., 2004; Mandić and Rancić, 2011) .
Stroke is among the leading causes of death in Western countries, surpassed only by heart disease and cancer (Donnan et al., 2008) . A recent update published in the United States reported that each year, approximately 55,000 more women than men have a stroke. Furthermore, epidemiological studies claim that females have a higher lifetime risk of stroke than males, mainly among those 55-75 years of age with an incidence of 1 in 5 for women (20-21%) compared to 1 in 6 for men (14-17%) (Go et al., 2013; Kleindorfer et al., 2010; Seshadri et al., 2006) . In addition to the high risk of stroke among females, recent studies have shown a marked change in the ethanol consumption profile in females, with an early consumption during adolescence often in a heavy binge-drinking manner (INPAD, 2013) . Surprisingly, despite the evidence that ethanol exposure is a risk factor for stroke and that females are more susceptible to ethanol's deleterious effects especially during adolescence, there are no studies addressing whether ethanol exposure during adolescence exacerbates stroke-induced damage or alters treatment efficacy for stroke-related symptoms in female subjects.
In addition to the high mortality rate, over 50% of patients with stroke exhibit some motor impairment (Bonita, 1992) . Tissue plasminogen activator (tPA) is the only drug approved for the treatment of acute ischemic stroke (Carpenter et al., 2011) . However, its clinical application is associated with several limitations such as narrow therapeutic windows (dose should be given no more than 3 h after stroke) and the risk of hemorrhage must be ruled out (Kablau et al., 2011) . Furthermore, it has been estimated that only 6 in 1000 patients benefit from this therapeutic resource (Gilligan et al., 2005; O'Donnell et al., 2010) .
Considering the paucity of approved therapies for stroke, several studies have investigated new putative therapeutic agents, including minocycline (Moskowitz et al., 2010; Yong et al., 2004) . Minocycline is a semi-synthetic tetracycline with pleiotropic actions and neuroprotective effects in acute and chronic neural disorders, including stroke (Cardoso et al., 2013; Franco et al., 2012; Yrjanheikki et al., 1999) , amyotrophic lateral sclerosis (Gordon et al., 2008 ), Parkinson's disease (Thomas and Le, 2004 ), Huntington's disease (Hodl and Bonelli, 2005) , multiple sclerosis (Chen et al., 2011) , head trauma (Homsi et al., 2010) and spinal cord trauma (Casha et al., 2012) .
The neuroprotective effects of minocycline have been attributed to multiple potential mechanisms (Yong et al., 2004) , but its effects on microglial activity is considered of great importance, as neuroinflammation plays a pivotal role in the pathophysiology of several CNS diseases (Block et al., 2007; Gomes-Leal, 2012) . For ischemia, minocycline has been shown to decrease the infarct area by about 65% for the cortex and by about 45% for the striatum following middle cerebral artery occlusion (MCAO) (Yrjanheikki et al., 1999) . We have reported considerable neuroprotection afforded by minocycline in the endotheline-1 (ET-1) model of focal ischemia in both the cortex (Franco et al., 2012) and striatum (Cardoso et al., 2013) . Microglia activation and proliferation have been implicated in the pathophysiology of ethanol intoxication (Blanco and Guerri, 2007; Zhao et al., 2012) . It has been shown that a low concentration of ethanol induces an inflammatory response in the CNS with the release of nitric oxide (NO) and proinflammatory cytokines by microglia (Blanco and Guerri, 2007) . Activation of toll-like receptors (i.e., toll-like receptors type 4 -TLR-4) and release of transcription factors (i.e., nuclear factor kappa B -NF-κB) seem to be involved in the mechanisms of ethanol-induced brain inflammation (Blanco and Guerri, 2007) .
Considering that minocycline is a potent anti-inflammatory/antibiotic tetracycline with well-established neuroprotective effects (Yrjanheikki et al., 1999; Franco et al., 2012;  b r a i n r e s e a r c h 1 5 6 1 ( 2 0 1 4 ) 2 3 -3 4 Cardoso et al., 2013) , we wondered whether minocycline treatment would be neuroprotective in ischemic rats chronically intoxicated with ethanol. Moreover, considering that ethanol exposure is a risk factor for stroke and that females are more susceptible to ethanol's deleterious effects especially during adolescence, in the present study we investigated whether chronic ethanol exposure during adolescence may potentiate the motor impairments and histological damage induced by focal ischemia in female rats and whether these effects can be mitigated by minocycline.
Results

2.1.
Effects of chronic ethanol exposure during adolescence on body weight gain in rats
As illustrated in Fig. 1 , the chronic ethanol (6.5 g/kg/day) administration over a period of 55 days (i.e., from the 35th day until the 90th day of life) induced a significant reduction in the body weight gain of rats from the 63rd to 77th days of life (F 8,128 ¼2.68; Po0.05). However, the final body weight of control-and ethanol-treated rats after the period of 55 days of treatment did not differ statistically.
2.2.
Minocycline mitigates ethanol-induced exacerbation of locomotor activity deficits and motor incoordination in ischemic rats
The results of locomotor activity evaluated in the open field arena (for 5 min) are summarized in Fig. 2A . Two-way ANOVA (pretreatment vs. treatment) revealed significant effects for Fig. 2A) .
The effects of chronic ethanol administration during adolescence and focal motor cortex ischemia on the rats' ability to maintain postural stability evaluated in the inclined plane test are illustrated in Fig. 2B that both ethanol exposure and focal motor cortex ischemia induced a significant decrease in the mean angle score when compared to the control group (Po0.05). However, ethanol intoxication during adolescence did not exacerbate the impairments induced by ischemia. Remarkably, these postural stability impairments induced by ischemia and ethanol intoxication in the inclined plane test were reversed by the minocycline treatment (Fig. 2B) .
The effects of chronic ethanol administration during adolescence and focal motor cortex ischemia on the motor coordination and balance of rats evaluated in the rotarod test are illustrated in Fig. 2C . Two-way ANOVA with repeated measures revealed no significant effect of the pretreatment factor [F 1,54 ¼ 0.52; P¼ 0.47]. However, it indicated significant effects for the treatment [F 2,54 ¼ 76.85; Po0.0001] and the repetition factor [F 2,108 ¼ 29.33; Po0.0001] and the interaction factor between pretreatment, treatment and repetition [F 4,108 ¼4.59; Po0.01]. Post-hoc comparisons revealed that focal ischemia induced a significant decrease in the latencies to fall in the test session 1 (T1), and that ethanol exposure during adolescence exacerbated these impairments since ethanol-ischemic animals displayed a poor performance in the subsequent test session 2 (T2). More importantly, the minocycline treatment improved the motor incoordination induced by focal ischemia and ethanol intoxication, as indicated by the significant increase in the latencies to fall in all test sessions (Fig. 2C ).
2.3.
Minocycline inhibits microglial activation in the motor cortex of ischemic rats subjected to ethanol intoxication during adolescence
The effects of minocycline treatment on microglial activation in the motor cortex of ischemic rats treated chronically with distilled water or during adolescence are shown in Fig. 3 . Two-way ANOVA (pretreatment vs. treatment) revealed significant effects for the main factors [pretreatment: F 1,24 ¼7.20; Po0.01; treatment: F 2,24 ¼ 372.26; Po0.0001] and their interaction [F 2, 24 ¼ 4.95; Po0.05] in the number of ED1þcells in the motor cortex. Post-hoc comparisons indicated that there was an increase in microglial activation in both ischemic groups (distilled water or ethanol). Interestingly, ethanol administration significantly reduced the number of activated macrophages by ED1þcells labeled in the motor cortex of ischemic rats when compared to the group that received distilled water during adolescence. More importantly, minocycline treatment significantly reduced the number of ED1þmicroglial cells in the motor cortex of ischemic rats even in those chronically treated with ethanol during adolescence (Fig. 3) .
2.4.
Minocycline protects against pyramidal neuron loss in the motor cortex of rats induced by ethanol intoxication and focal ischemia
The effects of chronic administration of ethanol during adolescence and focal ischemia in pyramidal cell density analyzed by cresyl violet staining in histological sections of the motor cortex of rats are shown in Fig. 4 . Two-way ANOVA (pretreatment vs. treatment) revealed significant effects for the main factors [pretreatment: 
Discussion
In the present study, we investigated whether chronic ethanol exposure during adolescence influences the ischemic outcome following ET-1-induced focal ischemia in the rat motor cortex in female rats. In addition, we explored minocycline's effects on this experimental paradigm. The current findings demonstrate, for the first time, that chronic ethanol exposure during adolescence exacerbates locomotor activity and motor coordination impairments induced by focal ischemia in female rats as evaluated in the open field and rotarod tests, respectively. Moreover, histological analysis revealed that microinjections of ET-1 induced focal infarcts with pyramidal neuron loss and microglial activation in the motor cortex of animals treated with distilled water or ethanol. Of high importance, the treatment with minocycline reversed the observed motor impairments, microglial activation and pyramidal neuron loss in the motor cortex of ischemic rats even in those chronically exposed to ethanol during adolescence. Previous studies have shown that ethanol intoxication induces CNS damage, which is related to an increased inflammatory response (Blanco and Guerri, 2007; Fernandez-Lizarbe et al., 2009; Qin and Crews, 2012a; Zhao et al., 2012) . Microglia activation seems to play an important role in the pathophysiology of ethanol intoxication (Fernandez-Lizarbe et al., 2009; Qin and Crews, 2012b; Zhao et al., 2012) . For instance, it has been shown that increased expression of monocyte chemoattractant protein-1 (MCP-1) and ionized calcium binding adapter molecule 1 (Iba-1) is associated with microglia activation in the brains of alcoholics (He and Crews, 2008) . In addition, 
ethanol intoxication induces activation of microglia and TLR4, which represent important players of ethanol-associated neuroinflammation since TLR4 knockout mice do not display neuroinflammation following ethanol exposure (FernandezLizarbe et al., 2009) . The correlation between the neuroinflammatory effects of ethanol and the modulation of glial activation by minocycline has been reported (Agrawal et al., 2011; Wu et al., 2011) . These studies demonstrated that several behavioral/functional impairments observed following ethanol intoxication could be related to the neuroimmune activity of glial cells, thus, minocycline emerges as a potential therapeutic drug. Recent in vitro (Boyadjieva and Sarkar, 2013) and in vivo (Qin and Crews, 2012a, b; Zhao et al., 2012) studies confirmed that ethanol intoxication induces neuroinflammation, including microglia activation. In such studies, ethanol induced excessive activation of nicotinamide adenine dinucleotide phosphate-oxidase (NADPH-oxidase) with a concomitant increase of reactive oxygen species production and NF-κB transcription in both experimental animals and humans (Qin and Crews, 2012a) . In addition, the same group showed that these inflammatory events are related to activation of TLR, with increased release of the tumor necrosis factor alpha (TNF-α) and reactive oxygen species, and increased NADPHoxidase activity (Qin and Crews, 2012b ).
In the current chronic ethanol intoxication protocol, the observed cortical tissue damage was not directly associated with microglia activation. Nevertheless, a modest number of ED1þ cells were observed in the CNS parenchyma, which is consistent with a previous study (McClain et al., 2011) . In McClain's paper, a partial activation of microglia in the hippocampus of male Sprague-Dawley rats was observed following binge alcohol exposure during adolescence, a phenomenon that was persistent into adulthood, suggesting that alcohol exposure during this unique developmental time period has long-lasting consequences.
In the present study, we observed that chronic ethanol intoxication during adolescence exacerbates the deleterious effects of focal ischemia in locomotor activity and motor coordination in female rats, and that minocycline partially reversed this phenomenon. Acute ethanol intoxication induces neurodegeneration, microglia activation and learning and memory deficits in the early days following intoxication (Zhao et al., 2012) . Our data shed light on this, by showing that chronic ethanol intoxication during adolescence induces tissue damage and motor impairment that are exacerbated in the event of stroke and, more importantly, that these events are reversed by minocycline.
The mechanisms by which minocycline affords neuroprotection and behavioral recovery in this experimental paradigm remain unknown, but the possible mechanisms may underly actions on microglia and other non-inflammatoryrelated effects. Previous studies have demonstrated minocycline as a potent anti-inflammatory and neuroprotective agent (Cardoso et al., 2013; Franco et al., 2012; Hayakawa et al., 2008; Yrjanheikki et al., 1999; Yong et al., 2004) . Despite its pleiotropic effects, inhibition of microglial activation is considered an important mechanism of action of minocycline (Hayakawa et al., 2008; Yrjanheikki et al., 1999; Yong et al., 2004) . On the other hand, data from in vitro rat brain homogenate lipid peroxidation and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assays show that minocycline, in contrast to tetracycline, is an effective antioxidant with radical scavenging potency similar to vitamin E (Kraus et al., 2005) . Therefore, these findings suggest that the direct antioxidant activity of minocycline may also contribute to its neuroprotective effects in animal models of neuronal injury.
Minocycline reduces both cortical and striatal infarct areas up to 45% and 65% following middle cerebral artery occlusion (MCAO) (Yrjanheikki et al., 1999) . This effect was associated with reduced microglia activation as well as neuroinflammation/neuroimmune response (Yrjanheikki et al., 1999; Blandino et al., 2006) . Actually, minocycline inhibited the release of interleukin-1 beta (IL-1β) and reduced the expression of cyclooxygenase 2 (COX-2) and prostaglandin E2 (Yrjanheikki et al., 1999 ) in brain ischemic areas. Furthermore, minocycline also acts by anti-apoptotic mechanisms by decreasing the release of cytochrome C from mitochondria and other apoptotic factors into the cytoplasm, thus, preventing the activation of caspase-3 and 9, which reduced cell death by apoptosis (Zhu et al., 2002) . Minocycline also regulates the cleavage and expression of B-cell lymphoma 2 (Bcl-2), which accumulates itself in the mitochondria and reduces the activation of the pro-apoptotic Bcl-2-like protein 4 (Bax), BH3 interacting-domain death agonist (Bid) and Bcl-2 homologous antagonist/killer (Bak) (Antonenko et al., 2010; Griffin et al., 2010) . Reduction of matrix metalloproteinase (MMP) activation by minocycline has been also described (Brundula et al., 2002) . It has been shown that minocycline may act on the hypothalamus by decreasing the levels of IL-1β after a stress response (footshock) (Blandino et al., 2006 (Blandino et al., , 2009 . Norepinephrine at adrenergic receptors appears to be fundamental for the IL-1β response after stress, and microglial inhibition by minocycline is responsible for immune response reductions in the CNS through the activity of noradrenergic receptors on microglia (Blandino et al., 2006) . In the CNS, the hypothalamus is a significant site of integration for the stressor stimulus, and stress increases in corticosterioid levels are responsible for modulating interleukin-1 (IL-1) expression in response. Blandino et al. (2006) also demonstrated that minocycline increases basal corticoid levels that were not observed in the presence of stress conditions (footshock). These authors suggest that the action of minocycline to block the hypothalamic IL-1β response is not a consequence of corticosteriod-mediated suppression. On the other hand, evidence highlights that alcohol exposure during adolescence produces long-term consequences on the adult brain stress circuitry (Logrip et al., 2013) , thus, the alcohol protocol used in our study may contribute to the deleterious effects of stroke observed that were reduced by minocycline. Moreover, according to Blandino et al. (2006) microglia may be a primary cellular source of IL-1β in the brain during the stress response, and the authors report that one probable mechanism of stress-induced exacerbation of neurodegenerative disorders may be microglia activation elicited by stressor conditions. In this sense, minocycline emerges as a relevant drug, further by its CNS specificity, blocking the neuroimmune response to stress exposure.
Considering that microglia activation seems to contribute to the combined pathophysiology of stroke and ethanol b r a i n r e s e a r c h 1 5 6 1 ( 2 0 1 4 ) 2 3 -3 4 intoxication on pyramidal cell loss, it is reasonable to suppose that the beneficial effects of minocycline treatment can modulate neuronal loss related to multiple ischemic causes and may potentially have more universal neuroprotective applicability. Nevertheless, considering the pleiotropic effects of minocycline, other actions may be involved and this should be addressed in additional studies.
It must be considered that microglia activation may also be related to neuroprotective events following stroke (LalancetteHebert et al., 2007; Neumann et al., 2006 Neumann et al., , 2008 and ethanol intoxication (Zhao et al., 2012) . Following oxygen-glucose deprivation (OGD) in hippocampal slices, 3D two-photon microscopy analysis revealed that microglia physically interact with neurons, potentially protecting these cells from ischemic damage (Neumann et al., 2006) . The same group has shown that microglia provide protection following ischemia by phagocytosis (Neumann et al., 2008) . In addition, genetic ablation of proliferating microglia exacerbates the ischemic damage, manifested by increases in pro-inflammatory cytokines, apoptosis and infarct areas following experimental MCAO in mice (Lalancette-Hebert et al., 2007) .
Following ethanol intoxication, microglia may serve both neuroprotective and detrimental actions (Zhao et al., 2012) . While in the acute phase of ethanol intoxication microglia were shown to contribute to damage, they seem to be neuroprotective in the abstinence phase (Zhao et al., 2012) . Consequently, anti-inflammatory approaches must be devised to maximize the beneficial actions of neuroinflammation, while reducing their detrimental effects. Complete inhibition of microglia activation is counterintuitive in experimental models of CNS diseases, as in the present study. It is likely that minocycline partially performs these desirable effects (Gomes-Leal, 2012).
In conclusion, our results provide the new evidence that the exposition of ethanol during adolescence exacerbates the motor impairments associated with motor cortex focal ischemia. Of significance are the current findings indicating that minocycline treatment improves both tissue damage and functional recovery in ischemic female rats, including those chronically exposed to ethanol during adolescence. The exact mechanisms involved in the observed minocycline neuroprotective effects should be investigated in future research, but the present data provide promising evidence that minocycline may be useful for the treatment of CNS damage induced by the combination of stroke plus ethanol intoxication. It is a feasible approach considering that minocycline is already used in the clinic for inflammatory diseases (Yong et al., 2004) and has been shown to be a promising neuroprotective drug for human stroke (Fagan et al., 2010; Lampl et al., 2007) .
4.
Experimental procedures
Animals
A total of 60 adolescent female (35 days old in the beginning of the experiments) Wistar rats were obtained from the Federal University of Pará (UFPA) and kept in collective cages (five animals per cage). Animals were maintained in a climatecontrolled room on a 12-h reverse light/dark cycle (lights on 7:00 a.m.), with food and water ad libitum. All procedures were approved by the Ethics Committee on Experimental Animals of the Federal University of Pará under license number BIO-007-09 and followed the guidelines suggested by the NIH Guide for the Care and Use of Laboratory Animals.
Experimental groups
Animals were initially allocated to the following groups: distilled water (n¼ 30) or ethanol (6.5 g/kg/day, 22.5% w/v) (n ¼30). Every day, rats were administered through orogastric cannula over a period of 55 days (i.e., until the 90th day of life) according to a procedure previously described (Maier and West, 2001; Maia et al., 2009) . The current protocol of ethanol administration was based on previous studies from our group (Maia et al., 2009) showing that ethanol intoxication (6.5 g/kg/day) in the developing CNS may induce long-lasting neurobehavioural impairments in rats. To investigate putative effects of ethanol intoxication on overall poor nutrition levels that may directly affect the motor performance cortical damage following focal ischemia, the animals' body weight was controlled during the entire period of ethanol administration. The animals were then divided into six experimental groups (n¼10 animals per group), as follows: (i) nonischemic rats treated with distilled water (oral pathway, p.o.), stereotaxically injected with sterile saline (0.9% NaCl) and intraperitoneally (i.p.) with sterile saline; (ii) rats treated with distilled water submitted to focal ischemia through microinjections of endotheline-1 (ET-1) and treated with sterile saline; (iii) rats treated with distilled water submitted to focal ischemia and treated with minocycline (i.p.); (iv) rats treated with ethanol (p.o.), stereotaxically injected with sterile saline and treated with sterile saline; (v) rats treated with ethanol submitted to focal ischemia and treated with sterile saline; (vi) rats treated with ethanol submitted to focal ischemia and treated with minocycline (see Fig. 5 ).
The animals' survival rate in each group was assessed throughout the entire experimental protocol period. No death was observed within the 55 days of repeated administration of ethanol as well as after the treatments with ET-1 and/or minocycline (data not shown). Moreover, all the behavioral, histopathological and immunohistochemical analyses were performed by an experienced experimenter who was unaware of the experimental group of the animals tested.
Surgery and experimental model of focal ischemia
After ethanol or distilled water administration, animals were submitted to focal ischemia through microinjections of ET-1 as described previously by Franco et al. (2012) . ET-1 is a potent vasoconstrictor decreasing about 70-80% of the local blood flow, and it is well established that ET-1 microinjections represent a valid model of focal ischemia (Agnati et al., 1991; Hughes et al., 2003) and is widely used by our group (Cardoso et al., 2013; Franco et al., 2012) . The animals were anesthetized with a mixture ketamine hydrochloride (72 mg/kg, i.p.) and xylazine (9 mg/kg, i.p.) and positioned in a stereotaxic apparatus (model RU-336, Insight s , Brazil). After craniotomy, 40 pmol of ET-1 (Sigma-Aldrich, USA) in 1 mL of sterile saline were injected into the left motor cortex using a b r a i n r e s e a r c h 1 5 6 1 ( 2 0 1 4 ) 2 3 -3 4
glass capillary micropipette (Sigma-Aldrich, USA). The pipette was left in place for 5 min before being slowly withdrawn. Control animals were injected with the same volume of sterile saline. We used the following stereotaxic coordinates for the ET-1 injection (in millimeters relative to bregma) according to Paxinos and Watson (2007) : 2.3 mm lateral; 1.2 mm posterior; 0.4 mm below the pial surface.
Minocycline treatment
Minocycline treatment of ischemic animals started at 2 h post-ischemia induction and continued for the following seven consecutive days (Fig. 5) . Minocycline (Sigma-Aldrich, USA) was administered by i.p. route at a dose of 50 mg/kg 12/12 h over 2 days after ischemia, and subsequently in a dose of 25 mg/kg, once a day, up to the 7th day post-ischemia (Ekdahl et al., 2003; Guimarães et al., 2010) . Control animals were i.p. injected with the same volume with sterile saline.
Open field
The spontaneous locomotor activity of the animals was evaluated in an open field arena for 5 min. The apparatus, made of wood covered with impermeable Formica, had a white floor of 100 Â 100 cm (divided by black lines into 25 squares of 20 Â 20 cm) and white walls, 40 cm high. Each rat was placed at the center of the open field and the numbers of squares crossed were registered.
Inclined plane
The animal's ability to maintain postural stability was evaluated with the inclined plane test. The rats were placed on the inclined plane, which is raised in 51 increments and can be used as an index of hindlimb strength (Murphy et al., 1995) . The maximum inclination at which the rat could maintain its position for 5 s was recorded as the final angle.
Each rat was tested in five consecutive trials with an intertrial interval of 60 s, and the average angle was calculated.
Rotarod
The rotarod apparatus (Insight s , Brazil) consists of a grooved metal roller (8 cm in diameter) and separated 9-cm wide compartments elevated 16 cm. As a part of the test procedure, animals were initially trained to maintain themselves on the rotating rod at 15 rpm for a period of more than 3 min (habituation phase). Subsequently, after a period of 24 h, the animals were evaluated for their ability to remain on the rotating rod for three successive trials of 3 min each (Sharma et al., 2009 ).
Histopathological and immunohistochemistry analyses
The lesion area was visualized in coronal sections (20-and 50-μm thick) stained with cresyl violet. The site of ET-1 injection was recognized by the presence of colanyl blue and through the tissue pallor associated with the loss of cell bodies. In order to analyze both pyramidal neuron density and microglial activation, we resorted to standard stained and immunohistochemical procedures, respectively. The density of pyramidal neurons was evaluated in 50-mm sections stained with cresyl violet. Neurons were recognized by the presence of their visible nuclei displaying a pyramidal morphology. Activated microglia/macrophages were labeled using the antibody ED1 (1:500, Serotec, UK), which binds to an epitope on the lysosomal membrane of activated macrophages and microglia.
The immunohistochemical procedures are described in detail in our previous study (Gomes-Leal et al., 2005) . Briefly, the slide-mounted sections were removed from the freezer, kept in an oven at 37 1C for 30 min and rinsed in 0.1 M phosphate buffer saline (PBS) for 5 min. In order to improve labeling intensity, sections were treated with 0.2 M boric acid b r a i n r e s e a r c h 1 5 6 1 ( 2 0 1 4 ) 2 3 -3 4 (pH 9.0) previously heated to 65 1C for 25 min. This temperature was maintained constant over the treatment period. Sections were allowed to cool down for about 20 min and incubated under constant agitation in an 1% hydrogen peroxide solution in methanol for 20 min. Sections were then rinsed in 0.05% PBS/Tween (Sigma Company, USA) solution for 5 min for three times and incubated with 10% normal horse serum in PBS for 1 h. Without further rinsing, sections were then incubated overnight with the primary antibody in PBS, rinsed in PBS/Tween solution for 5 min (three times), and incubated with biotinylated horse anti-mouse (ED1 antibody) secondary antibodies (Vector Laboratories, USA) diluted 1:500 in PBS for 2 h. As a negative control, normal serum, rather than primary antibody, were used in some sections. Sections were rinsed again for 5 min (three times) and incubated in the avidin-biotin-peroxidase complex (ABC Kit, Vector Laboratories, USA) for 2 h. Sections were rinsed four times (5 min each) and revealed with 3,3 0 -diaminobenzidine (DAB) (Gomes-Leal et al., 2005) . After the DAB reaction, sections were rinsed two times (5 min each) in 0.1 M PB, dehydrated, and coverslipped with Entellan (Merck, Germany).
Qualitative and quantitative analyses
All sections were initially surveyed by light microscopy. Illustrative images from all experimental groups were obtained with a digital camera (Moticam 2500) attached to a microscope (Nikon, Eclipse 50i). We used coronal sections containing the damaged motor cortex to count the numbers of pyramidal cells and activated macrophages/microglia (ED1þcells/mm 2 ) using a 0.0665-mm 2 square graticule attached to the microscope eyepiece (objective 40 Â ). We counted three fields per section and three sections per animal for all experimental groups. The regions of interest had the highest cell density along a line passing through the lesion center (central field), and two additional fields were chosen at 1-mm intervals (1 mm medially and 1 mm laterally) (Fig. 6 ) (Schnell et al., 1999) .
Statistical analysis
All values are expressed as means7S.E.M. (n ¼10 animals per group for behavioral tests and n ¼4-5 per group for histological analyses). Statistical comparison of body weight gain between control and ethanol groups was performed using one-way analysis of variance (ANOVA) with repeated measures (days). Data from rotarod tests were evaluated with two-way ANOVA (pretreatment vs. treatment) with repeated measures (trials). The rest of the data was compared using two-way ANOVA with pretreatment (water vs. ethanol) and treatment (control vs. ET-1 vs. ET-1 plus minocycline) as independent variables. Following significant ANOVAs, multiple post-hoc comparisons were performed using Tukey's test. The accepted level of significance was Po0.05. All tests were performed using the Statistica software package (StatSoft Inc., Tulsa, OK, USA).
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